Literature DB >> 2445930

Photodynamic therapy for palliation of locally recurrent breast carcinoma.

M Schuh1, U O Nseyo, W R Potter, T L Dao, T J Dougherty.   

Abstract

Fourteen women with locally recurrent breast carcinoma on the chest wall following mastectomy were given 30 courses of photodynamic therapy (PDT). All patients had been heavily pretreated with conventional modes of therapy (radiation therapy, chemotherapy, hormonal therapy, surgical resection). Twenty-two courses yielded a partial response; two courses yielded a complete response; four courses showed no response; one patient was treated as an adjunct to surgery; and one patient was lost to follow-up. Duration to response was variable, ranging from 6 weeks to 8 months. Several women had chest wall disease controlled for prolonged periods of time using repeated courses of PDT. Two women had re-epithelialization of ulcerated lesions. Complications were minimal and included pain (two patients), sunburn (two), and infection (one). These results suggest that treatment with PDT can aid in local control of chest wall recurrence following mastectomy in selected patients.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 2445930     DOI: 10.1200/JCO.1987.5.11.1766

Source DB:  PubMed          Journal:  J Clin Oncol        ISSN: 0732-183X            Impact factor:   44.544


  10 in total

1.  Anti-angiogenic activity of selected receptor tyrosine kinase inhibitors, PD166285 and PD173074: implications for combination treatment with photodynamic therapy.

Authors:  C J Dimitroff; W Klohs; A Sharma; P Pera; D Driscoll; J Veith; R Steinkampf; M Schroeder; S Klutchko; A Sumlin; B Henderson; T J Dougherty; R J Bernacki
Journal:  Invest New Drugs       Date:  1999       Impact factor: 3.850

Review 2.  A review of progress in clinical photodynamic therapy.

Authors:  Z Huang
Journal:  Technol Cancer Res Treat       Date:  2005-06

3.  Toxicities and early outcomes in a phase 1 trial of photodynamic therapy for premalignant and early stage head and neck tumors.

Authors:  Peter H Ahn; Harry Quon; Bert W O'Malley; Gregory Weinstein; Ara Chalian; Kelly Malloy; Joshua H Atkins; Thomas Sollecito; Martin Greenberg; Sally McNulty; Alexander Lin; Timothy C Zhu; Jarod C Finlay; Keith Cengel; Virginia Livolsi; Michael Feldman; Rosemarie Mick; Theresa M Busch
Journal:  Oral Oncol       Date:  2016-02-08       Impact factor: 5.337

4.  Photodynamic therapy for breast cancer in a BALB/c mouse model.

Authors:  Tae-Gyu Ahn; Byoung-Rai Lee; Eun-Young Choi; Dong Won Kim; Sei-Jun Han
Journal:  J Gynecol Oncol       Date:  2012-04-03       Impact factor: 4.401

5.  The effect of combined modality treatment with ionising radiation and TPPS-mediated photodynamic therapy on murine tail skin.

Authors:  K Benstead; J V Moore
Journal:  Br J Cancer       Date:  1990-07       Impact factor: 7.640

6.  Vitamin D enhances the efficacy of photodynamic therapy in a murine model of breast cancer.

Authors:  Kishore R Rollakanti; Sanjay Anand; Edward V Maytin
Journal:  Cancer Med       Date:  2015-02-25       Impact factor: 4.452

7.  The place of extensive surgery in locoregional recurrence and limited metastatic disease of breast cancer: preliminary results.

Authors:  M Berlière; F P Duhoux; L Taburiaux; V Lacroix; C Galant; I Leconte; L Fellah; F Lecouvet; D Bouziane; Ph Piette; B Lengele
Journal:  Biomed Res Int       Date:  2015-03-18       Impact factor: 3.411

8.  A Tumor-pH-Responsive Supramolecular Photosensitizer for Activatable Photodynamic Therapy with Minimal In Vivo Skin Phototoxicity.

Authors:  Xingshu Li; Bi-Yuan Zheng; Mei-Rong Ke; Yongfan Zhang; Jian-Dong Huang; Juyoung Yoon
Journal:  Theranostics       Date:  2017-07-07       Impact factor: 11.556

9.  Enhancement of photodynamic therapy by mitomycin C: a preclinical and clinical study.

Authors:  P Baas; I P van Geel; H Oppelaar; M Meyer; J H Beynen; N van Zandwijk; F A Stewart
Journal:  Br J Cancer       Date:  1996-04       Impact factor: 7.640

10.  The novel EpCAM-targeting monoclonal antibody 3-17I linked to saporin is highly cytotoxic after photochemical internalization in breast, pancreas and colon cancer cell lines.

Authors:  Kaja Lund; Monica Bostad; Ellen Skarpen; Michael Braunagel; Sergej Kiprijanov; Stefan Krauss; Alex Duncan; Anders Høgset; Pål K Selbo
Journal:  MAbs       Date:  2014 Jul-Aug       Impact factor: 5.857

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.